glp1 vs semaglutide Zepbound GLP-1 vs Wegovy: What's the Difference Tirzepatide vs Semaglutide: what's the

It also results in decreased physical activity and exercise, reducing overall calorie expenditure

This is because extra fat can block the airway

Metformin primarily reduces glucose production in the liver and increases insulin sensitivity

[2] A Quiet but Important FDA Move On April 30, 2026, the FDA announced a proposal that did not generate much mainstream news coverage

What clinicians consider when advising against GLP-1 use during breastfeeding Lack of large, controlled lactation safety trials Unknown effects on infant growth or neurodevelopment Uncertainty about effects on milk supply or composition Elective nature of GLP-1 therapy for weight loss Availability of safer alternatives after breastfeeding ends Why FDA and medical guidance remains cautious FDA and specialty guidance emphasize caution during breastfeeding for several consistent reasons: Insufficient data: FDA labeling states there are inadequate data on GLP-1 medication effects in breastfed infants.,, Milk supply unknowns: It is not known whether GLP-1 medications affect milk supply (volume) or milk composition., Infant vulnerability: Early infancy is a sensitive developmental period, increasing caution when medication effects are unknown. Elective vs essential use: For weight management, potential maternal benefit often does not outweigh theoretical infant risk.,, Do semaglutide and tirzepatide pass into breast milk